Childhood Cancer Stocks List
|PQSG||C||PGIM QMA Strategic Alpha Small-Cap Growth ETF||0.16|
|IWC||D||iShares Microcap ETF||0.03|
|OMFS||C||Oppenheimer Russell 2000 Dynamic Multifactor ETF||0.02|
|VTWO||C||Vanguard Russell 2000 ETF||0.01|
|VTWG||D||Vanguard Russell 2000 Growth ETF||0.01|
View all Childhood Cancer related ETFs...
Childhood cancer is cancer in a child. In the United States, an arbitrarily adopted standard of the ages used are 0–14 years inclusive, that is, up to 14 years 11.9 months of age. However, the definition of childhood cancer sometimes includes adolescents between 15–19 years old. Pediatric oncology is the branch of medicine concerned with the diagnosis and treatment of cancer in children.
Worldwide, it is estimated that childhood cancer has an incidence of more than 175,000 per year, and a mortality rate of approximately 96,000 per year. In developed countries, childhood cancer has a mortality of approximately 20% of cases. In low resource settings, on the other hand, mortality is approximately 80%, or even 90% in the world's poorest countries. In many developed countries the incidence is slowly increasing, as rates of childhood cancer increased by 0.6% per year between 1975 and 2002 in the United States and by 1.1% per year between 1978 and 1997 in Europe. Unlike cancers in adults, which typically arise from years of DNA damage, childhood cancers are caused by a misappropriation of normal developmental processes.